SanBio Company Limited
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
4592 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区明石町８番１号
- Website:
- https://www.sanbio.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SanBio Company Limited is a biotechnology firm dedicated to the research, development, production, and commercialization of regenerative cell medicines. The company focuses on creating novel treatments for severe neurological disorders, aiming to restore functions lost due to injury or disease. Its primary pipeline targets conditions affecting the central nervous system, such as chronic motor deficits resulting from traumatic brain injury and stroke. SanBio's lead product candidate, SB623 (marketed in Japan as AKUUGO®), is an allogeneic cell therapy developed to improve motor function in patients. The company leverages its proprietary technology for large-scale production to address significant unmet medical needs in neurology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-12 08:31 |
Regulatory News Service
確認書
|
Japanese | 7.9 KB | ||
| 2025-09-12 08:31 |
Interim Report
半期報告書－第13期(2025/02/01－2026/01/31)
|
Japanese | 230.6 KB | ||
| 2025-06-13 08:45 |
Regulatory News Service
臨時報告書
|
Japanese | 19.2 KB | ||
| 2025-04-24 08:31 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 23.7 KB | ||
| 2025-04-23 08:31 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | ||
| 2025-04-23 08:31 |
Regulatory News Service
内部統制報告書－第12期(2024/02/01－2025/01/31)
|
Japanese | 21.6 KB | ||
| 2025-04-23 08:30 |
Annual Report
有価証券報告書－第12期(2024/02/01－2025/01/31)
|
Japanese | 1.3 MB | ||
| 2025-03-17 07:30 |
Earnings Release
臨時報告書
|
Japanese | 21.2 KB | ||
| 2025-02-14 07:30 |
Registration Form
有価証券届出書（参照方式）
|
Japanese | 168.5 KB | ||
| 2024-12-25 07:30 |
Regulatory News Service
臨時報告書
|
Japanese | 19.3 KB | ||
| 2024-12-02 07:30 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 112.5 KB | ||
| 2024-09-17 08:02 |
Regulatory News Service
臨時報告書
|
Japanese | 19.0 KB | ||
| 2024-09-17 08:01 |
Report Publication Announcement
確認書
|
Japanese | 7.9 KB | ||
| 2024-09-17 08:01 |
Interim Report
半期報告書－第12期(2024/02/01－2024/07/31)
|
Japanese | 181.0 KB | ||
| 2024-06-13 08:02 |
Regulatory News Service
臨時報告書
|
Japanese | 19.0 KB |
Automate Your Workflow. Get a real-time feed of all SanBio Company Limited filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SanBio Company Limited via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
